期刊文献+

冬凌草甲素自微乳给药系统的体外释放动力学研究 被引量:10

Release kinetics of oridonin self-microemulsifying drug delivery system in vitro
下载PDF
导出
摘要 目的:研究冬凌草甲素自微乳给药系统的体外释放特性,探讨释药机制。方法:利用HPLC测定冬凌草甲素的含量,以反向透析法进行冬凌草甲素自微乳的体外释放实验,考察释放介质、搅拌速度和处方因素对药物释放的影响。采用相似因子法比较释药曲线的相似性,利用药物释放模型方程拟合释放曲线。结果:释放介质对药物释放无显著影响;在50~100r·min^-1药物释放曲线具有相似性;冬凌草甲素自微乳与乙醇溶液的释放曲线相似;冬凌草甲素自微乳在pH7.8PBS中,30min释放达65%,释放曲线符合Hixson—Crowell方程。结论:冬凌草甲素自微乳释药较快,在水性环境中自发形成的微小乳滴在释药过程中粒径和表面积均发生改变,药物分子透膜为被动扩散过程。 Objective: To investigate the release characteristics and mechanism of oridnonin self-microemulsifying drug delivery system (SMEDDS) in vitro. Method: The concentration of oridonin was determined by HPLC. In vitro release studies were conducted by reverse dialysis technique. The effects of release medium, agitation rate and preparations on the oridonin release were studied. The similarity factor (f2) was applied to the release profile comparisons. Model fitting was used to determine the kinetics and mechanism. Result: The release media and agitation rate from 50-100 r · min^-1 had no distinctive effect on the oridonin release kinetics, which the similarity factors were greater than 50.. The oridonin release profdes for oridonin SMEDDS and oridonin ethanol solution were similar. 65% of oridonin were released in 30 rnin for oridonin SMEDDS in pH 7.8 PBS. Oridonin SMEDDS fit the Hixson-Crowelt model best. Conclusion: The release data from oridonin SMEDDS showed it release fast. The deduced release mechanism is that the surface and particle sizes of seff-microemulsion in water solution are changing during the process of release and the drug penetration through membrane is a passive diffusion process.
出处 《中国中药杂志》 CAS CSCD 北大核心 2008年第18期2049-2052,共4页 China Journal of Chinese Materia Medica
基金 上海市教委重点学科建设项目(J50302)
关键词 冬凌草甲素 自微乳给药系统 体外释放动力学 反向透析法 oridonin self-microemulsifying drug delivery system in vitro release kinetics reverse dialysis technique
  • 相关文献

参考文献7

  • 1李瑛 张覃林.冬凌草甲素对体外无细胞DNA的影响[J].中国药理学报,1988,9(5):465-465.
  • 2Liu Jiajun, Huang Renwei, Lin Dongjun, et al. Anti-proliferative effects of oridonin on SPC-A-1 cells and its mechanism of action [J]. J Int Med Res, 2004,32(6) :617.
  • 3Porter C J H, Trevaskis N, Charman W N. Lipids and hpid-based formulations: optimizing the oral delivery of lipophilic drugs [ J ]. Nature Reviews: Drug Discovery, 2007,6(3) :231.
  • 4刘华,李三鸣,袁悦,郎轶咏,刘凯.酮洛芬自乳化制剂的释药动力学研究[J].沈阳药科大学学报,2005,22(2):91-95. 被引量:11
  • 5陈鹰,李高,李海平,王瑞华.长春西汀自微乳化释药系统的体外释药特性研究[J].中国药师,2006,9(12):1092-1095. 被引量:6
  • 6Wu Wei, Wang Yang, Que Li. Enhanced bioavailability of silymatin by self-microemulsifying drug delivery system [ J ]. Eur J Pharm Biopharm, 2006,63(3) :288.
  • 7Abraham R, Yashwan V P, Jackie K, et al. In vitro release and intestinal absorption of physostigmine salicylate from submicro emulsions[J]. J Pharm Sci, 1991,80(7) :643.

二级参考文献10

  • 1Ashington C. Drug release from microdisperse systems: a critical review [J].Int J Pharm, 1990,58(1) :1 - 12.
  • 2Levy MY, Benita S. Drug release from submicronized O/W emulsion: a new in vitro kinetic evaluation model[J]. Int J Pharm, 1990, 66(1 - 3) :29 - 37.
  • 3Shah N H, Carvajal M T, Patel C I. Self - emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs [J]. Int J Pharm, 1994, 106(1):15-23.
  • 4Hauss DJ,Fogal SE,Ficorilli JV,et al.Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly wAter-soluble LTB4 inhibitor[J].J Pharm Sci,1998,87 (2):164-169
  • 5Bereczki D,Fekete I.A systematic review of vinpocenne therapy in acute ischaemic stroke[J].Eur J Clin Pharmacol,1999,55:349-352
  • 6Miskolczi P,Korma K,Polgar M,et al.Pharmacokinetics of vinpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans[J].Eur J Drug Metab Pharmacokinet,1990,15:1-5
  • 7Ashington C.Drug release from microdisperse systems:a critical review[J].Int J Pharm,1990,58(1):1-12
  • 8Pudleiner P,Vereczkey L.Study on the absorption of vinpocetine and apovincaminic acid[J].Eur J Drug Metab Pharmacokinet,1993,18(4):317 -321
  • 9李国栋,范伟,居红卫,王捷频,张建明.自乳化释药系统的研究进展[J].国外医药(合成药.生化药.制剂分册),2001,22(5):304-305. 被引量:29
  • 10潘卫三,李华,李嘉煜,姜晓薇.长春西汀体外经皮渗透性实验中接受液的选择[J].沈阳药科大学学报,2002,19(4):239-243. 被引量:11

共引文献16

同被引文献2052

引证文献10

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部